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CASE REPORT
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of the Literature
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Syringomas are common intraepidermal sweat gland tumors most oftenfound in women around the
time ofadolescence. Frequent sites ofinvolvement include the lower eyelids and malar areas, however
vulvar involvement is relatively rare. These lesions oftenpresent as small, multiple, skin-colored-to-
yellowish papules and are often associated with increased vulvar discomfort and itching. Wepresent
a case ofa 29-year oldfemale whopresented to her gynecologist complaining ofvulvar itching and
burning. A snall condylomatous-type wart observed on her vulva was biopsied andfound to be a
syringoma. Because oftheir clinicalpresentation andassociated symptoms, vulvar syringomas should
be considered in the differential diagnosis ofany multicentric papular lesion ofthe vulva, vulvar
pain syndrome, andpruritis vulvae.
INTRODUCTION
Syringomas are common appendageal
tumors ofthe intraepidermal eccrine sweat
gland ducts. Their occurrence is twice as
common in women than men, with adoles-
cence being the most common time ofonset
[1].However,furtherlesionscandevelop later
in life, and reported cases range between
the first and sixth decades of life [2-7].
Clinically, syringomas appear as small,mul-
tiple, firm, skin-colored-to-yellowish papules,
1 to 3 mm in diameter, localized most
commonly to the lower eyelids and malar
areas, but can also occur in the axillae,
neck, chest, upper arms, and abdomen.The
lesions usually are bilateral and symmetri-
cally distributed [4]. Vulvar syringoma is a
relatively rare occurrence, with only a few
cases reported in the literature to date.
CASE
A29-year-old GO P0 female presented
in June to her gynecologist for evaluation
ofvulvar itching and burning oftwo weeks
duration.b She denied any significant past
medical or gynecologic history, or recent
oral contraceptive use. She also denied any
family history of hereditary diseases.
Pregnancy test was negative.
On physical examination, a small
condylomatous-type wart was observed on
the right vulva. Biopsy performed atthe time
revealed histologic changes mostconsistent
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with syringoma, however because the lesion
extended to the base of the resection, the
possibility ofamicrocystic eccrinecarcinoma
could not be excluded.Asubsequent excision
of the right inferior vulva with skin con-
firmed the diagnosis of vulvar syringoma.
Since the time of final diagnosis, the
patient reports no further occurrence of
syringoma, either on her vulva or any other
part of her body.
DISCUSSION
Syringoma was first described in 1872
by Kaposi and Biesiadeki as Lymphangioma
Tuberosum Multiplex [8, 9]. Since then,
monoclonal antikeratin antibody tests,
electron microscopy, and histochemistry
have all confirmed the intraepidermal
eccrine sweat gland nature of this disease
[10]. These tumors are most common in
females, present during adolescence, and
most commonly involve the face [11].
Syringomas are typically non-regressing
and asymptomatic, although malignancy
has been reported [12].There is an increased
frequency of this disease among oriental
females and patients suffering from Down's
syndrome [13, 14]. Although numerous
reports exist in the literature describing
families with a history of this disease [10,
11, 15, 16], the hereditary transmission has
not been elucidated.
Biopsy with microscopic examination
is key to establishing the diagnosis and to
ruling out other diseases. Histologically,
the epidermis is normal. However, further
examination of the upper dermis and mid-
dermis reveals a plethora of small colloid-
material-containing cystic ducts and solid
epithelial strands contained within the sur-
rounding fibrous stroma ofthese two layers
[7]. Two rows of flat epithelial cells with
clear cytoplasm line the walls of these
ducts [17, 18], although cuboidal cells may
sometimes be found lining the lumen as
well [17]. At the end ofthe ducts are often
found comma shaped "tadpole" tails com-
prised ofbulgings formed by weakly orga-
nized ductal structures.
Friedman and Butler have suggested
four principle classifications of syringomas
based on morphological features and associ-
ations [19]. The first is localized disease,
occurring either as solitary or multiple
lesions. The second is a generalized, mul-
tifocal pattern of disease. The third group
of cases is associated with Down's syn-
drome, and the fourth are familial cases of
syringoma.
The firstpatients with vulvar syringoma
were reported by Carneiro et al. in 1971
[5]. The prevalence of this tumor may be
greater than previously reported due to the
fact that many are asymptomatic and are
unrecognized by both patient and clinician
[5]. Because vulvar syringomas have com-
monly been described in association with
extragenital lesions [5, 11, 20] examination
of the rest of the body, especially the eye-
lids and malar areas, is essential when a
suspected syringoma is found in the vulvar
region. Likewise, examination ofthe vulvar
skin is mandatory when this lesion is found
outside the genital area.
Although the diagnostic and treatment
modalities for vulvar syringomas remains
the same as at each location throughout the
body, the vulvar area presents a special
diagnostic challenge to the physician trying
to make a diagnosis. Syringoma should be
seriously considered in the differential
diagnosis of any multicentric papular
lesion of the vulva, vulvar pain syndrome,
andpruritis vulvae. Clinically, some patients
with vulvar syringomas may complain of
increasing discomfort and itching, espe-
cially during warmer months or during
menstruation [10, 11]. The differential
diagnosis for vulvar syringoma is broad,
and biopsy with histologic examination
may exclude such diseases as epidermal
cyst, steatocystoma multiplex, lymphan-
gioma circumstriptum, lichen simplex
chronicus, Fox-Fordyce angiokeratomas
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natum, candidiasis, scabies, pediculosis,
allergic and irritant contact dermatitis, pso-
riasis, and lichen sclerosis et atrophicus [6,
21,22].
It has been suggested that syringomas
are hormonally responsive based on obser-
vations that they increase in size during
pregnancy, the premenstrual period, with
the use of oral contraceptives, and are
known to occur most commonly in women
and during puberty [1, 23, 24]. In a study
of nine non-vulvar syringomas from both
males and females, Wallace et al. demon-
strated estrogen in one case and proges-
terone in the remaining eight syringomas
by immunohistochemical staining [1]. In a
recentcasereport byYorganci etal., immuno-
histochemistry of a vulvar syringoma was
shown to display progesterone positivity
[25]. Both studies supplement clinical obser-
vations that syringomas may contain hor-
monally active receptors that influence their
progression during hormonally active states.
Treatment for syringomas is usually
not necessary, and is often performed at
visible areasofthe bodyforcosmeticreasons,
or ifit symptomatic. Syringomas commonly
do not improve following medical thera-
pies with topical steroids or ointments [7,
11, 17, 26], and thus treatment must be sur-
gical. Partial removal, either by excision,
electrodessication, and carbon dioxide laser
treatment can be performed with satisfac-
tory results [3,4, 11, 21].Although pruritis
may resolve, tumor recurrence and scar for-
mation following treatment are common. In
one case report, Belardi et al. favored the
use of cryotherapy with nitrogen oxide
because ofits minimal aggressiveness. The
patient tolerated therapy and the lesions
healed quickly without scarring [7].
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